Half-year report · Q2
4202.TEDINET S100UOID
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥289.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥558.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥271.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥31.6bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥26.6bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥30.7bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥68.4bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥30.7bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥41.8bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥40.1bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥32.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥55.8bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥29.8bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥32.6bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥29.9bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥827.8bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥839.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥808.6bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥435.5bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥463.8bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥392.3bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥375.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥355.8bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥64.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥73.2bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥64.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥68.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥92.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥93.5bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥50.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥76.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥49.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥29.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥55.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥26.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥24.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥52.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥28.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥116.18 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥197.56 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥104.13 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 45.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 65
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥9.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥2.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥344m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥13.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥13.8bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥124.6bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥124.5bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥96m |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥15.2bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥95.1bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥88.5bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.6bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.3bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥7.2bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥7.2bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥0 |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥189m |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥47.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥47.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥19.6bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥19.6bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥51m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥215m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥293.6bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥286.9bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥31.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥303.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥289.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥13.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥31.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥9.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥2.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥6.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥122m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥11.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥11.8bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥108.8bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥108.7bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥71m |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥6.1bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥90.9bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥89.0bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥19.9bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥6.9bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥6.9bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥481m |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥47.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥47.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥140m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥19.7bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥16.8bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥133m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥273.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥268.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥4.8bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥282.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥271.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥26.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 581
| Item | Context | Value | Unit |
|---|---|---|---|
| Loss gain on sales and retirement of noncurrent assets ope cf | CurrentYTDDuration | 271000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | -9712000000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | -6756000000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | CurrentYTDDuration | -4543000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -2627000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 11318000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -658000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -5022000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 7872000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 3432000000 | JPY |
| Other net ope cf | Prior1YTDDuration | 8915000000 | JPY |
| Other net ope cf | CurrentYTDDuration | 294000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 57568000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 58299000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 1982000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 1783000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -808000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -685000000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -9549000000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -8651000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 49192000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 50745000000 | JPY |
| Net decrease increase in time deposits inv cf | Prior1YTDDuration | -4165000000 | JPY |
| Net decrease increase in time deposits inv cf | CurrentYTDDuration | 4469000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -32576000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -43457000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 26000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 59000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -1165000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -1254000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -63000000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -147000000 | JPY |
| Proceeds from sales and redemption of investment securities inv cf | Prior1YTDDuration | 11400000000 | JPY |
| Proceeds from sales and redemption of investment securities inv cf | CurrentYTDDuration | 7844000000 | JPY |
| Payments of loans receivable inv cf | Prior1YTDDuration | -4000000 | JPY |
| Payments of loans receivable inv cf | CurrentYTDDuration | -4000000 | JPY |
| Collection of loans receivable inv cf | Prior1YTDDuration | 406000000 | JPY |
| Collection of loans receivable inv cf | CurrentYTDDuration | 502000000 | JPY |
| Proceeds from sales of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from sales of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | 3527000000 | JPY |
| Other net inv cf | Prior1YTDDuration | -630000000 | JPY |
| Other net inv cf | CurrentYTDDuration | -932000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -26773000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -29391000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | -6264000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | -6907000000 | JPY |
| Net increase decrease in short term bonds payable fin cf | Prior1YTDDuration | -10000000000 | JPY |
| Net increase decrease in short term bonds payable fin cf | CurrentYTDDuration | -14000000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | 9519000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |